KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Consolidated Net Income (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed Consolidated Net Income for 17 consecutive years, with -$67.5 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income rose 31.67% to -$67.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.2 million through Dec 2025, up 137.4% year-over-year, with the annual reading at $78.2 million for FY2025, 137.39% up from the prior year.
  • Consolidated Net Income hit -$67.5 million in Q4 2025 for Nu Skin Enterprises, down from $17.1 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $107.5 million in Q1 2025 to a low of -$118.2 million in Q2 2024.
  • Historically, Consolidated Net Income has averaged $981300.0 across 5 years, with a median of $9.8 million in 2023.
  • Biggest five-year swings in Consolidated Net Income: crashed 1462.97% in 2024 and later soared 21646.09% in 2025.
  • Year by year, Consolidated Net Income stood at -$54.6 million in 2021, then soared by 86.56% to -$7.3 million in 2022, then surged by 198.65% to $7.2 million in 2023, then plummeted by 1462.97% to -$98.7 million in 2024, then surged by 31.67% to -$67.5 million in 2025.
  • Business Quant data shows Consolidated Net Income for NUS at -$67.5 million in Q4 2025, $17.1 million in Q3 2025, and $21.1 million in Q2 2025.